The FDA's new First Generics Policy has evoked a positive response from leaders of the generic drug industry, who are predicting that the action will speed the marketing of lower-cost prescription medicines. "Ensuring that at least one generic medicine will be available to consumers when a brand's patent expires is good news for consumers," officials at the Generic Pharmaceutical Association (GPhA) said.
Because of the FDA's action, "consumers will have more timely access to safe, effective, and affordable generic medicines," GPhA said. "By making generics more accessible, [the] FDA is saving consumers and our entire health care system millions of dollars."
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs